u/lane_watcher

Pharmacy staff name removed. The pharmacy can stay in a pricing post.

Was it shipped from a regional warehouse or from origin?

Referral link removed and the post left up. No links of any kind here, and that rule is not negotiable.

Province added to the title. Coverage is provincial and the thread could not be answered without it.

a lane with four reports is not yet a lane

valeria_karlsen is right about regional stock. It changes the shape of the distribution, not just the mean.

the last mile is where most of the variance lives

Flagged as describing the superseded compounded arrangements — left up with a note rather than removed.

a quoted lead time you can hold them to is worth more than a fast one you cannot

declared value and description are the shipper’s decision, ask what they use

a quoted lead time you can hold them to is worth more than a fast one you cannot

Referral link removed and the post left up. No links of any kind here, and that rule is not negotiable.

Left up. It distinguishes a rejected claim from a denied authorization, which most posts here do not.

Nothing containing this compound is approved anywhere. Research-use-only material is not approved for human use, and that is a statement of fact rather than a disclaimer.

Left up and added to the lane table. All four required fields were present, which is rarer than it should be.

Pharmacy pricing on a private prescription is set by the pharmacy. The spread between them in a given month is routinely substantial, which is why a tracker built from member reports is more useful than any headline.

Careful with the rankings. A phase 2 result and a phase 3 result are not on the same evidential footing and cannot be listed in one table.

Withdrawal studies across this class consistently show substantial regain after discontinuation, with appetite typically returning before weight changes. That is a description of the pharmacology of a chronic condition.

Nearly sent on the wrong network. The token symbol was identical and the address format was the only clue.

Pointing this one at somebody qualified locally. Nothing on this board is legal advice.

Kept a spreadsheet of quoted versus actual across a year. The quote held; the variance was all in the last mile.

an online consultation that asks you nothing is not a consultation

Yes — the shortage database is the source. The news coverage of it is downstream and usually a week behind.

Province added to the title. Coverage is provincial and the thread could not be answered without it.

Pharmacy names are fine in pricing posts; staff names are not.

Country added to the title. Without it the answers will be confidently wrong.

the phase 2 numbers were striking and they were also 48 weeks in a small population

Correction: that was clearance time, not carrier time. The lane table separates them for exactly this reason.

say the province or the answers will be wrong

Left up. It names both countries and quotes the notice, which is exactly what makes these threads useful.

Discharge at goal, which nobody warns people about.

Specialist services in England are commissioned to deliver a defined intervention. Reaching goal is a successful outcome and it typically ends with discharge back to primary care. Whether prescribing continues after that is a local decision that varies, and plenty of members here have discovered it at the point of discharge rather than at the start.

The useful thing to do is ask early: what happens when I finish, and does prescribing continue in primary care in this area. Ask it in writing, keep the answer, and you will at least know which conversation you are heading for.

ask the supplier what documentation accompanies the shipment

This is why every thread here has to start with a country.

Asked for the month rather than removing. Without it the report cannot be compared to anything.

Small fix — three receptors, not two. GLP-1, GIP and glucagon, and the third one is the reason this compound gets its own board.

It is a triple agonist at the GLP-1, GIP and glucagon receptors. The glucagon arm is the genuinely novel component and it is the one with the least human outcome data behind it.

cold_chromatogram31 is right that regional stock is the structural answer rather than a trick.

This is why every thread here has to start with a country.

the median is more useful than the fastest anybody ever got

Asked for the month rather than removing. Without it the report cannot be compared to anything.

say the province or the answers will be wrong

a streamlined authority code is not the same as a general listing

The two routes, described separately, because mixing them is where most of the confusion here starts.

The NHS route in England runs through specialist weight management services commissioned by your ICB. Criteria, waiting times and what happens at discharge are all local decisions, which is why a confident answer from somebody in a different area may be wrong for you.

The private route is an independent transaction: a consultation, a prescription and a pharmacy price. It does not affect your position on any NHS list and it is not a shortcut through one. Both are legitimate; they are simply not the same pathway and they do not connect.